SonisS.T.Oral complications of cancer therapy. In: DeVitaV.T., HellmanS., RosenbergS.A., eds. Cancer: Principles and Practice of Oncology.4th ed.Philadephia, Pa: JB Lippincott Co; 1993: 2385–2394.
2.
VerdiC.J.Cancer therapy and oral mucositis. Drug Saf.1993; 9: 185–195.
3.
AllegraC.J.Antifolates. In: ChabnerB., CollinsJ.M., eds. Cancer Chemotherapy: Principles and Practice.Philadelphia, Pa: JB Lippincott Co; 1990: 110–153.
4.
FerrettiG.A., RaybouldT.P., BrownA.T.Chlorhexidine prophylaxis for chemotherapy- and radiotherapy-induced stomatitis: a randomized, double-blind trial. Oral Surg Oral Med Oral Pathol.1990; 69: 331–337.
5.
McGawW.T., BelchA.Oral complications of acute leukemia: prophylactic impact of a chlorhexidine mouth rinse regimen. Oral Surg Oral Med Oral Pathol.1985; 60: 275–280.
6.
FerrettiG.A., AshR.C., BrownA.T.Control of mucositis and candidiasis in marrow transplantation: a prospective, double-blind trial of chlorhexidine oral rinse. Bone Marrow Transplant.1988; 3: 483–493.
7.
PrestonS.L., BricelandL.L.Fluconazole for antifungal prophylaxis in chemotherapy- inudced neutropenia. Am J Health Syst Pharm.1995; 52: 164–173.
8.
SaralR., BurnsW.H., LaskinO.L.Acyclovir prophylaxis of herpes-simplex-virus infections. N Engl J Med.1981; 305: 63–67.
9.
CarnelS.B., BlakesleeD.B., OswaldS.G.Treatment of radiation- and chemotherapy-induced stomatitis. Otolaryngol Head Neck Surg.1990; 102: 326–330.
10.
LevyM.H.Constipation and diarrhea in cancer patients. Cancer Bull.1991; 43: 412–422.
11.
WadleighR.G., RedmanR.S., GrahamM.L.Vitamin E in the treatment of chemotherapy-induced mucositis. Am J Med.1992; 92: 481–484.
12.
PfeifferP., MadsenE.L., HansenO.Effect of prophylactic sucralfate suspension on stomatitis induced by cancer chemotherapy: a randomized, double-blind cross-over study. Acta Oncol.1990; 29: 171–173.
13.
PortederH., RauschE., KmentG.Local prostaglandin E2 in patients with oral malignancies undergoing chemo- and radiotherapy. J Craniomaxillofac Surg.1988; 16: 371–374.
14.
LabarB., MrsicM., PavleticZ.Prostaglandin E2 for prophylaxis of oral mucositis following BMT. Bone Marrow Transplant.1993; 11: 379–382.
15.
FaureM., LissiE.A., VidelaL.A.Antioxidant capacity of allopurinol in biological systems. Biochem Int.1990; 21: 357–366.
16.
HowellS.B., WungW.E., TaetleR.Modulation of 5-fluorouracil toxicity by allopurinol in man. Cancer.1981; 48: 1281–1289.
TsavarisN., CaragiaurisP., KosmidisP.Reduction of oral toxicity of 5-fluorouracil by allopurinol mouthwashes. Eur J Surg Oncol.1988; 14: 405–406.
19.
LoprinziC.L., CianfloneS.G., DoseA.M.A controlled evaluation of an allopurinol mouthwash as prophylaxis against 5-fluorouracil-induced stomatitis. Cancer.1990; 65: 1879–1882.
20.
QuilitzR., PerkinsJ., ZorskyP. Lack of effect of allopurinol on the incidence and severity of gastrointestinal complications of high dose paclitaxel, mitoxantrone, and thiotepa. Abstract pending.
21.
MillsE.E.The modifying effect of beta-carotene on radiation and chemotherapy induced oral mucositis. Br J Cancer.1988; 57: 416–417.
22.
AhmedT., EngelkingC., SzalygaJ.Propantheline prevention of mucositis from etoposide. Bone Marrow Transplant.1993; 12: 131–132.
23.
RussellJ.A., WoodmanR.C., PoonM.C.Addition of low-dose folinic acid to a methotrexate/cyclosporin A regimen for prevention of graft-versus-host disease. Bone Marrow Transplant.1994; 14: 397–401.
24.
BiancoJ.A., ApplebaumF.R., NemunaitisJ.Phase I-II trial of pentoxifylline for the prevention of transplant-related toxicities following bone marrow transplantation. Blood.1991; 78: 1205–1211.
25.
StockschladerM., KalhsP., PetersS.Intravenous pentoxifylline failed to prevent transplant-related toxicities in allogeneic bone marrow transplant recipients. Bone Marrow Transplant.1993; 12: 357–362.
26.
AttalM., HuguetF., RubieH.Prevention of regimen-related toxicities after bone marrow transplantation by pentoxifylline: a prospective, randomized trial. Blood.1993; 82: 732–736.
27.
van der JagtR.H., PariG., McDiarmidS.A.Effect of pentoxifylline on regimen related toxicity in patients undergoing allogeneic or autologous bone marrow transplantation. Bone Marrow Transplant.1994; 13: 203–207.
28.
BiancoJ.A.Pentoxifylline and ciprofloxacin effects on regimen related toxicities following allogeneic bone marrow transplantation. Exp Hematol.1991: 938. Abstract.
29.
GabriloveJ.L., JakubowskiA., ScherH.Effect of granulocyte colony-stimulating factor on neutropenia and associated morbidity due to chemotherapy for transitional-cell carcinoma of the urothelium. N Engl J Med.1988; 318: 1414–1422.
30.
BronchudM.H., HowellA., CrowtherD.The use of granulocyte colony- stimulating factor to increase the intensity of treatment with doxorubicin in patients with breast and ovarian cancer. Br J Cancer.1989; 60: 121–125.
31.
PettengellR., GurneyH., RadfordJ.A.Granulocyte colony-stimulating factor to prevent dose-limiting neutropenia in non-Hodgkinòs lymphoma: a randomized controlled trial. Blood.1992; 80: 1430–1436.
32.
MahoodD.J., DoseA.M., LoprinziC.L.Inhibition of fluorouracil-induced stomatitis by oral cryotherapy. J Clin Oncol.1991; 9: 449–452.
33.
RockeL.K., LoprinziC.L., LeeJ.K.A randomized clinical trial of two different durations of oral cryotherapy for prevention of 5-fluorouracil-related stomatitis. Cancer.1993; 72: 2234–2238.
34.
Pourreau-SchneiderN., SoudryM., FranquinJ.C.Soft-laser therapy for iatrogenic mucositis in cancer patients receiving high-dose fluorouracil. J Natl Cancer Inst.1992; 84: 358–359.
